Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

CDC-Authored Genomics and Precision Health Publications Database|Home|PHGKB

CDC-Authored Genomics and Precision Health Publications Database


Last data update: May 20, 2022. (Total: 3839 publications since 2011)
   dataset
Filtered By:
Records 1-13 (of 13 Records)
Query Trace: all>>James E Posey[CDC Author]
Molecular evaluation of fluoroquinolone resistance in serial Mycobacterium tuberculosis isolates from individuals diagnosed with multidrug-resistant tuberculosis.
Melisa Willby, Paige Chopra, Darrin Lemmer, Katherine Klein, Tracy L Dalton, David M Engelthaler, Peter Cegielski, James E Posey, and
Antimicrobial agents and chemotherapy 2020 Oct
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Patricia J Campbell, Glenn P Morlock, R David Sikes, Tracy L Dalton, Beverly Metchock, Angela M Starks, Delaina P Hooks, Lauren S Cowan, Bonnie B Plikaytis, and James E Posey
Antimicrobial agents and chemotherapy 2011 May 55(5) 2032-41
Isoniazid- and Rifampin-Resistance Mutations Associated with Resistance to Second-line Drugs and with Sputum Culture Conversion.
Eleanor S Click, Ekaterina Kurbatova, Heather Alexander, Tracy L Dalton, Michael P Chen, James E Posey, Julia J Ershova, and Peter Cegielski
The Journal of infectious diseases 2020 Jan
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.
, Caroline Allix-Béguec, Irena Arandjelovic, Lijun Bi, Patrick Beckert, Maryline Bonnet, Phelim Bradley, Andrea M Cabibbe, Irving Cancino-Muñoz, Mark J Caulfield, Angkana Chaiprasert, Daniela M Cirillo, David A Clifton, Iñaki Comas, Derrick W Crook, Maria R De Filippo, Han de Neeling, Roland Diel, Francis A Drobniewski, Kiatichai Faksri, Maha R Farhat, Joy Fleming, Philip Fowler, Tom A Fowler, Qian Gao, Jennifer Gardy, Deborah Gascoyne-Binzi, Ana-Luiza Gibertoni-Cruz, Ana Gil-Brusola, Tanya Golubchik, Ximena Gonzalo, Louis Grandjean, Guangxue He, Jennifer L Guthrie, Sarah Hoosdally, Martin Hunt, Zamin Iqbal, Nazir Ismail, James Johnston, Faisal M Khanzada, Chiea C Khor, Thomas A Kohl, Clare Kong, Sam Lipworth, Qingyun Liu, Gugu Maphalala, Elena Martinez, Vanessa Mathys, Matthias Merker, Paolo Miotto, Nerges Mistry, David A J Moore, Megan Murray, Stefan Niemann, Shaheed V Omar, Rick T-H Ong, Tim E A Peto, James E Posey, Therdsak Prammananan, Alexander Pym, Camilla Rodrigues, Mabel Rodrigues, Timothy Rodwell, Gian M Rossolini, Elisabeth Sánchez Padilla, Marco Schito, Xin Shen, Jay Shendure, Vitali Sintchenko, Alex Sloutsky, E Grace Smith, Matthew Snyder, Karine Soetaert, Angela M Starks, Philip Supply, Prapat Suriyapol, Sabira Tahseen, Patrick Tang, Yik-Ying Teo, Thuong N T Thuong, Guy Thwaites, Enrico Tortoli, Dick van Soolingen, A Sarah Walker, Timothy M Walker, Mark Wilcox, Daniel J Wilson, David Wyllie, Yang Yang, Hongtai Zhang, Yanlin Zhao, and Baoli Zhu
The New England journal of medicine 2018 379(15) 1403-1415
Pathogen Genomics in Public Health.
Gregory L Armstrong, Duncan R MacCannell, Jill Taylor, Heather A Carleton, Elizabeth B Neuhaus, Richard S Bradbury, James E Posey, and Marta Gwinn
The New England journal of medicine 2019 Dec (26) 2569-2580
Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests.
Justin L Kandler, Alexandra D Mercante, Tracy L Dalton, Matthew N Ezewudo, Lauren S Cowan, Scott P Burns, Beverly Metchock, , Peter Cegielski, and James E Posey
Antimicrobial agents and chemotherapy 2018 Aug
Statistical Method to Detect Tuberculosis Outbreaks among Endemic Clusters in a Low-Incidence Setting.
Sandy P Althomsons, Andrew N Hill, Alexia V Harrist, Anne Marie France, Krista M Powell, James E Posey, Lauren S Cowan, and Thomas R Navin
Emerging infectious diseases 2018 Mar (3) 573-575
Detection of Mycobacterium tuberculosis pncA mutations by the NIPRO Genoscholar(™)·PZA-TB II as compared to conventional sequencing.
Melisa J Willby, Maria Wijkander, Joshua Havumaki, Kartee Johnson, Jim Werngren, Sven Hoffner, Claudia M Denkinger, and James E Posey
Antimicrobial agents and chemotherapy 2017 Oct
Rv3351c, a Mycobacterium tuberculosis gene that affects bacterial growth and alveolar epithelial cell viability.
Rebecca L Pavlicek, Kari Fine-Coulson, Tuhina Gupta, Frederick D Quinn, James E Posey, Melisa Willby, Jorge Castro-Garza, and Russell K Karls
Canadian journal of microbiology 2015 Oct 1-10
Mycobacterium tuberculosis pncA polymorphisms that do not confer pyrazinamide resistance at a breakpoint concentration of 100 µg/ml in MGIT.
Michael G Whitfield, Robin M Warren, Elizabeth M Streicher, Samantha L Sampson, Frik A Sirgel, Paul D van Helden, Alexandra Mercante, Melisa Willby, Kelsey Hughes, Kris Birkness, Glenn Morlock, Annelies van Rie, and James E Posey
J. Clin. Microbiol. 2015 Aug 19.
Disparities in capreomycin resistance levels associated with the rrs A1401G mutation in clinical isolates of Mycobacterium tuberculosis.
Analise Z Reeves, Patricia J Campbell, Melisa J Willby, and James E Posey
Antimicrob. Agents Chemother. 2015 Jan 59(1) 444-9
Antimycobacterial activity of DNA intercalator inhibitors of Mycobacterium tuberculosis primase DnaG.
Chathurada Gajadeera, Melisa J Willby, Keith D Green, Pazit Shaul, Micha Fridman, Sylvie Garneau-Tsodikova, James E Posey, and Oleg V Tsodikov
J. Antibiot. 2015 Mar 68(3) 153-7
New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations.
Seidu Malik, Melisa Willby, David Sikes, Oleg V Tsodikov, and James E Posey
PLoS ONE 2012 7(6) e39754
TOP